127 related articles for article (PubMed ID: 2423993)
1. [Membrane and thyroglobulin antibodies in Graves-Basedow disease treated with I-131 or thyrostatics].
Czech W; Krzaścik E; Gardas A; Jastrzebska H; Bednarski A
Pol Tyg Lek; 1986 Feb; 41(5):142-4. PubMed ID: 2423993
[No Abstract] [Full Text] [Related]
2. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
[TBL] [Abstract][Full Text] [Related]
3. [Reflections on the therapeutic goal in Basedow hyperthyroidism].
Höfer R
Acta Med Austriaca; 1987; 14(3-4):70-2. PubMed ID: 2447737
[TBL] [Abstract][Full Text] [Related]
4. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467
[TBL] [Abstract][Full Text] [Related]
5. [Occurrence of various autoantibodies in autoimmune diseases].
Lacka K; Jarczewska K; Gembicki M
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):751-3, 770. PubMed ID: 2641801
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
Hopf U; Fiek T; Grün R; Zuschneid W
J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
[TBL] [Abstract][Full Text] [Related]
7. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease.
Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R
Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026
[No Abstract] [Full Text] [Related]
8. [Personal experience in the study of thyroid autoimmunity and endocrine exophthalmos].
Winand R
Bull Mem Acad R Med Belg; 1989; 144(5-7):363-70; discussion 370-2. PubMed ID: 2575920
[TBL] [Abstract][Full Text] [Related]
9. Studies on a receptor assay for an antibody to human thyroid plasma membrane.
Ochi Y; Hosoda S; Hachiya T; Yoshimura M; Miyazaki T; Kajita Y
Acta Endocrinol (Copenh); 1979 May; 91(1):89-98. PubMed ID: 582221
[No Abstract] [Full Text] [Related]
10. [The significance of microsomal antibodies, thyroglobulin antibodies, thyrotropin receptor antibodies in the diagnosis of thyroid diseases].
Horster FA
Internist (Berl); 1988 Aug; 29(8):538-40. PubMed ID: 3053504
[No Abstract] [Full Text] [Related]
11. [The development of a radioimmunological method for determining autoantibodies to thyroglobulin].
Shcherban' AI; Cherkesova TS; Bogdanovich AF; Vasilevskiĭ VI; Demidchik EP; Minaĭlo TI
Probl Endokrinol (Mosk); 1990; 36(3):72-5. PubMed ID: 2395841
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].
Sussi PL; Burro A; Plebani M; Abrescia F; Perazzolo E; Petronio R
Chir Ital; 1984 Aug; 36(4):643-7. PubMed ID: 6549274
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic criteria in terminating therapy in Basedow hyperthyroidism].
Ogris E
Acta Med Austriaca; 1987; 14(3-4):77-84. PubMed ID: 2447740
[TBL] [Abstract][Full Text] [Related]
14. Thyroid antibodies in Graves' disease. An immunofluorescence study.
Szabó J; Leövey A
Acta Med Hung; 1983; 40(2-3):91-7. PubMed ID: 6366729
[TBL] [Abstract][Full Text] [Related]
15. An investigation of pedigrees of 110 patients with Graves' disease and the clinical significance of determinations of antithyroid antibodies of their first-degree relatives.
Wang DQ; Wang JZ; Ren JM; Zhou XT; Peng WC
Chin Med J (Engl); 1994 Nov; 107(11):817-21. PubMed ID: 7867387
[TBL] [Abstract][Full Text] [Related]
16. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
17. Triiodothyronine autoantibodies in Graves' disease: their changes after antithyroid therapy and relationship with the thyroglobulin antibodies.
Wang PW; Huang MJ; Liu RT; Chen CD
Acta Endocrinol (Copenh); 1990 Jan; 122(1):22-8. PubMed ID: 1689529
[TBL] [Abstract][Full Text] [Related]
18. The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease.
Bromberg N; Werner RS; Sgarbi JA; Werner MC; Romaldini JH
Exp Clin Endocrinol; 1991 May; 97(2-3):354-7. PubMed ID: 1717300
[No Abstract] [Full Text] [Related]
19. [Autoimmune reactions in diffuse toxic goiter after treatment with radioactive iodine].
Mazepa MA; Parashchak AP; Tomashivskaia LV; Rypan VS; Ivano-Frankovsk
Med Radiol (Mosk); 1976 Feb; 21(2):72-3. PubMed ID: 946323
[No Abstract] [Full Text] [Related]
20. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
Baker JR; Saunders NB; Kaulfersch W; Burman KD
J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
